Dabigatran etexilate mesylate drug class?

See the DrugPatentWatch profile for Dabigatran

What drug class is dabigatran etexilate mesylate?

Dabigatran etexilate mesylate is classified as an oral anticoagulant in the direct thrombin inhibitor (also called a direct factor IIa inhibitor) drug class. It works by directly inhibiting thrombin, which helps prevent clot formation. [1]

How does it compare to heparins and other blood thinners?

Compared with heparin or low–molecular-weight heparins (which enhance antithrombin’s effect), dabigatran is different because it directly inhibits thrombin (factor IIa) rather than relying on antithrombin.

What is it used for?

Dabigatran is used to reduce the risk of stroke and systemic embolism in certain patients with atrial fibrillation, and it’s also used for the treatment and prevention of venous thromboembolism (blood clots) in appropriate clinical settings. [1]

Why the “mesylate” name matters

“Dabigatran etexilate mesylate” is the salt form of the drug. The active pharmacologic agent is dabigatran, which is delivered as an etexilate prodrug that converts to dabigatran in the body. [1]

Sources:
[1] https://www.drugs.com/ingredient/dabigatran-etexilate-mesylate.html